SPOTLIGHT -
Madison, WI-The Implantable Contact Lens (ICL, STAAR Surgical) in eyes with moderate to high myopia produced at least comparable outcomes if not better than those achieved after LASIK, said John A. Vukich, MD.
Aurion Biotech doses first Canadian patient in Phase 1/2 ABA-1, CLARA clinical trial of AURN001
EyePod: Modifier Gene Therapy: What is it?
Navigating ocular effects of cancer therapy: Insights from breast cancer and head-neck cancers
EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery
ABVC BioPharma reaches global licensing deal for ophthalmology pipeline
Plastic surgery: When specialties overlap